Earlier this month, FDA officials met with Barr Pharmaceuticals to discuss the drug company's application to make Plan B emergency contraception (EC) available over the counter. Not coincidentally, the meeting was announced just one day before Senate confirmation hearings for President Bush's embattled nominee for FDA commissioner, Dr. Andrew von Eschenbach, -- the agency's acting director since September 2005. Since...